DOCSLIB.ORG

American Association of Endocrine Surgeons

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
American Association of Endocrine Surgeons THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS Thirty-Sixth Annual Meeting MAY 17-19, 2015 The Omni Nashville Hotel Nashville, TN THANK YOU The American Association of Endocrine Surgeons would like to thank the following companies for their generous support of our meeting through educational grants and sponsorships*: Platinum Level Support Neurovision Section of Surgical Sciences, Vanderbilt University Medical Center Gold Level Support Genzyme Silver Level Support Boston Medical Center Ethicon Bronze Level Support AstraZeneca Vanderbilt Endocrine and Eskind Diabetes Clinic Additional support from: Mary Ann Liebert Publishers and Veracyte The American Association of Endocrine Surgeons Foundation would like to thank the following company for their generous support of the Paul LoGerfo Educational Research Award through an annual grant: Elsevier, Inc. The American Association of Endocrine Surgeons gratefully acknowledges the support of the following exhibiting companies*: Akrimax Eisai, Inc. Medtronic Pharmaceuticals EndocrineWeb.com Memorial Healthcare Ambry Genetics Ethicon US, LLC System American Association of Future Diagnostics Neurovision Medical Clinical Endocrinologists GE Healthcare Products, Inc. (AACE) Genzyme, a Sanofi Olympus American Multiple Company Onyx Pharmaceuticals Neoplasia Support Sense Medical (AMEN) Graves’ Disease & Thyroid Foundation Shire American Thyroid Association (ATA) HealthBreeze ThyCa: Thyroid Cancer Survivors’ Association ArborMetrix, Inc. Hitachi Aloka Medical Thyroid Cancer Care CBLPath Interpace Diagnostics Invuity, Inc. Collaborative (TCCC) Covidien Veracyte, Inc. Special thanks to the AAES 2015 Publication and Program Committee Program Committee Rebecca S. Sippel, Chair Tobias Carling Kepal N. Patel Nancy D. Perrier, Melanie Goldfarb Scott M. Wilhelm Secretary-Treasurer Shelby A. Holt Linwah Yip Gerard Doherty, President John I. Lew Cord Sturgeon, Recorder Juan Pablo Pantoja *PARTICIPANTS AS OF MAY 4, 2015 AAES 2015 ANNUAL MEETING THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS Thirty-Sixth Annual Meeting MAY 17-19, 2015 Direct all correspondence to: American Association of Endocrine Surgeons 11300 W. Olympic Blvd., Suite 600, Los Angeles, CA 90064 T: 310-986-6452 n F: 310-437-0585 E: [email protected] AAES Secretary-Treasurer Nancy D. Perrier, MD, MD Anderson Cancer Center 1400 Pressler Street, Unit 1484, Houston, TX 77030 T: 713-794-1345 n F: 713-563-5727 E: [email protected] American Association of Endocrine Surgeons www.endocrinesurgery.org MAY 17-19, 2015 | NASHVILLE, TN 1 AAES FUTURE MEETINGS 2016 April 10-12, 2016 Baltimore, Maryland John A. Olson, Jr., MD, PhD 2017 TBD Mira Milas, MD 2018 Raleigh/Durham, North Carolina Julie Ann Sosa, MD 2019 Los Angeles, California Michael W. Yeh, MD THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS 2 36th ANNUAL MEETING TABLE OF CONTENTS Future Meetings . 2 Officers, Council & Committees . 4 Past Officers �����������������������������������������������������������������������������������������������������������������7 The Oliver Cope Meritorious Achievement Award Recipients . .11 Honorary Members ��������������������������������������������������������������������������������������������������� 13 Resident/Fellow Research Award Winners & Poster Competition Winners ���������������������������������������������������������������������������������14 2014-2015 New Members . 20 Contributors to the AAES Foundation & the Paul Logerfo Educational Research Fund . 22 Past Meetings . 24 Special Sessions . 26 Historical Lecturer �����������������������������������������������������������������������������������������������������27 Historical Lecturers at Recent Meetings �������������������������������������������������������������� 28 Invited Lecturer �������������������������������������������������������������������������������������������������������� 29 Invited Lecturers at Recent Meetings . 30 Conference Information ������������������������������������������������������������������������������������������ 33 Accreditation . 34 Hotel Information ������������������������������������������������������������������������������������������������������ 36 Agenda . 37 Scientific Program ���������������������������������������������������������������������������������������������������� 45 Abstracts . 57 Poster Displays . 127 Bylaws ����������������������������������������������������������������������������������������������������������������������� 137 Geographical Membership Directory ��������������������������������������������������������������������151 2015 Member Contact Information Sheet �����������������������������������������������������������166 In Memoriam . 167 Notes . 168 MAY 17-19, 2015 | NASHVILLE, TN 3 OFFICERS, COUNCIL & COMMITTEES PRESIDENT EDUCATION & RESEARCH COMMITTEE Gerard M. Doherty John A. Olson, Jr. — Chair Amelia C. Grover PRESIDENT ELECT Rachel Kelz Steven K. Libutti Amanda M. Laird James Lee VICE PRESIDENT Kelly L. McCoy William B. Inabnet Daniel T. Ruan Brian D. Saunders RECORDER David Velazquez Cord Sturgeon Rasa Zarnegar SECRETARY-TREASURER FELLOWSHIP COMMITTEE Nancy D. Perrier Tracy S. Wang — Chair Peter Angelos PAST PRESIDENT Tobias Carling Miguel F. Herrera Sally E. Carty PAST PRESIDENT Gerard M. Doherty Thomas Joseph Fahey III Ashok R. Shaha Paul G. Gauger PAST PRESIDENT Clive S. Grant Miguel F. Herrera Sally E. Carty Richard A. Hodin COUNCIL William B. Inabnet John A. Olson, Jr. Electron Kebebew Michael W. Yeh James Lee Sonia L. Sugg John I. Lew Sanziana A. Roman Janice L. Pasieka Rebecca S. Sippel Nancy D. Perrier Tracy S. Wang Richard Allen Prinz Bryan K. Richmond CESQIP COMMITTEE Sanziana A. Roman William B. Inabnet — Chair Daniel T. Ruan Sally E. Carty Wen T. Shen Paul G. Gauger Allan Siperstein Miguel F. Herrera Rebecca S. Sippel Naris Nilubol Samuel Kevin Snyder Janice L. Pasieka Michael W. Yeh David F. Schneider Martha A. Zeiger Carmen C. Solorzano Julie Ann A. Sosa THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS 4 36th ANNUAL MEETING OFFICERS, COUNCIL & COMMITTEES CONT. INFORMATION & TECHNOLOGY COMMITTEE David R. Farley — Co-Chair Nancy D. Perrier — Co-Chair Alan P.B. Dackiw Erin A. Felger Elizabeth G. Grubbs John I. Lew Barbra S. Miller Sareh Parangi Janice L. Pasieka Evandro C. Vasconcelos MEMBERSHIP COMMITTEE Michael W. Yeh — Chair Sanzania A. Roman Sonia L. Sugg NOMINATING COMMITTEE Ashok R. Shaha — Chair Sally E. Carty Gerard E. Doherty Miguel F. Herrera PROGRAM COMMITTEE Rebecca S. Sippel — Chair Tobias Carling Melanie Goldfarb Shelby A. Holt John I. Lew Juan Pablo Pantoja Kepal N. Patel Nancy D. Perrier Cord Sturgeon Scott M. Wilhelm Linwah Yip 2015 LOCAL ARRANGEMENTS COMMITTEE CHAIR Carmen C. Solorzano AD HOC ESU COMMITTEE Mira M. Milas — Chair Martha A. Zeiger — Co-Chair Gerard M. Doherty MAY 17-19, 2015 | NASHVILLE, TN 5 OFFICERS, COUNCIL & COMMITTEES CONT. COMMUNITY-BASED SURGEONS AACE REPRESENTATIVES COMMITTEE (CBS) Barbra S. Miller Sally Carty — Executive Council Advisor Cory L. Foster — Chair AMERICAN MEDICAL ASSOCIATION ENDOCRINE SECTION COUNCIL Julie Ann A. Sosa — Academic Liaison REPRESENTATIVE Shaghayegh Aliabadi-Wahle Richard James Harding Steven A. De Jong Doris Ann Quintana AAES JOB BOARD Mark S. Sneider Wen Shen Beth H. Sutton Eren Berber FELLOWSHIP ACCREDITATION AMERICAN BOARD OF SURGERY COMMITTEE SURGICAL ONCOLOGY BOARD Sonia L. Sugg — Chair Gerard M. Doherty Sally E. Carty Gary C. Clark AMERICAN COLLEGE OF SURGEONS Gerard M. Doherty BOARD OF GOVERNORS Paul G. Gauger Janice L. Pasieka Debra G. Koivunen Christopher R. McHenry AAES POSTER SESSION CHAIR John E. Phay Philip I. Haigh Nancy D. Perrier NSQIP REPRESENTATIVE Tracy S. Wang John H. Yim David McAneny AD HOC AAES PARATHYROIDECTOMY PAUL LOGERFO FUND GUIDELINES Jack Monchik Sally E. Carty — Chair AAES FOUNDATION Sylvia Asa Gerard M. Doherty Geoffrey Bruce Thompson — Chair Quan-Yang Duh Peter C. Angelos James Lee John A. Chabot Janice L. Pasieka William B. Inabnet III Nancy D. Perrier Jack Monchik Daniel T. Ruan Janice L. Pasieka Shonni Silverberg Robert Udelsman Carmen C. Solorzano Cord Sturgeon Mitchell E. Tublin Robert Udelsman Tracy S. Wang Scott Michael Wilhelm THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS 6 36th ANNUAL MEETING PAST OFFICERS 1980-1981 Norman W. Thompson . President Orlo H. Clark �������������������������������������������������������������������������������������������������������� Vice President John M. Monchik . Secretary-Treasurer 1981-1982 Norman W. Thompson . President Orlo H. Clark �������������������������������������������������������������������������������������������������������� Vice President John M. Monchik . Secretary-Treasurer 1982-1983 Edwin L. Kaplan . President Blake Cady . Vice President John M. Monchik . Secretary-Treasurer 1983-1984 Stanley R. Friesen ������������������������������������������������������������������������������������������������������ President John A. Palmer ���������������������������������������������������������������������������������������������������� Vice President John M. Monchik . Secretary-Treasurer 1984-1985 Leonard Rosoff . President John M. Monchik . Vice President Stuart D. Wilson ���������������������������������������������������������������������������������������� Secretary-Treasurer 1985-1986 Chiu-An Wang . President Edward Paloyan . Vice President Stuart D. Wilson ���������������������������������������������������������������������������������������� Secretary-Treasurer 1986-1987 Oliver Beahrs . President Robert C. Hickey . Vice President
Load more

Recommended publications
  • Endocrine Surgery Goals and Objectives
    Lenox Hill Hospital Department of Surgery Endocrine Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology of the diseases listed below for this rotation, with the pertinent clinical and laboratory findings, differential diagnosis and therapeutic options including preventive measures, and procedural knowledge. They must show that they are able to gather accurate and relevant information using medical interviewing, physical examination, appropriate diagnostic workup, and use of information technology. They must be able to synthesize and apply information in the clinical setting to make informed recommendations about preventive, diagnostic and therapeutic options, based on clinical judgement, scientific evidence, and patient preferences. They should be able to prescribe, perform, and interpret surgical procedures listed below for this rotation. All Residents are expected to understand: 1. Normal physiology and anatomy of the thyroid glands. 2. Normal physiology and anatomy of the parathyroid glands. 3. Normal physiology and anatomy of the adrenal glands 4. Normal physiology of the pancreatic neuroendocrine cells. 5. Normal physiology of the pituitary gland. Disease-Based Learning Objectives: Hyperfunctioning Thyroid and Hypothyroid State: 1. Physiology of Grave’s disease and toxic goiter. 2. Management of a patient in hyperthyroid storm. 3. Medical and surgical treatment options for hyperthyroidism. 4. Physiology of Hashimoto’s thyroiditis and hypothyroidism. Thyroid Neoplasm: 1. Workup of a cold thyroid nodule. 2. Surgical management of papillary, follicular, medullary, and anaplastic thyroid carcinoma. 3. Adjuvant therapy for thyroid neoplasms. 4. Postoperative medical management and long-term follow-up of thyroid cancer. Hyperparathyroidism: 1. Diagnosis and work-up of hypercalcemia and primary, secondary, and tertiary hyperparathyroidism.
    [Show full text]
  • Downloaded from Bioscientifica.Com at 09/30/2021 02:21:58AM Via Free Access
    27 8 Endocrine-Related C R C Pieterman, Future directives in 27:8 T9–T25 Cancer S M Sadowski et al. MEN1-related PanNETs THEMATIC REVIEW HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives C R C Pieterman1,2,*, S M Sadowski3,*, J E Maxwell4, M H G Katz4, K E Lines5, C M Heaphy6,†, A Tirosh7, J E Blau8, N D Perrier1, M A Lewis9,10, J P Metzcar11,12, D M Halperin13, R V Thakker5 and G D Valk2 1Section of Surgical Endocrinology, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands 3Endocrine Surgery, Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 4Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Academic Endocrine Unit, Radcliffe Department of Medicine, OCDEM, University of Oxford, Oxford, UK 6Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 7Neuroendocrine Tumors Service, Division of Endocrinology, Metabolism and Diabetes, The Chaim Sheba Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 8Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA 9Gastrointestinal Oncology, Intermountain
    [Show full text]
  • Surgical Indications and Techniques for Adrenalectomy Review
    THE MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL DOI: 10.14744/SEMB.2019.05578 Med Bull Sisli Etfal Hosp 2020;54(1):8–22 Review Surgical Indications and Techniques for Adrenalectomy Mehmet Uludağ,1 Nurcihan Aygün,1 Adnan İşgör2 1Department of General Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey 2Department of General Surgery, Bahcesehir University Faculty of Medicine, Istanbul, Turkey Abstract Indications for adrenalectomy are malignancy suspicion or malignant tumors, non-functional tumors with the risk of malignancy and functional adrenal tumors. Regardless of the size of functional tumors, they have surgical indications. The hormone-secreting adrenal tumors in which adrenalectomy is indicated are as follows: Cushing’s syndrome, arises from hypersecretion of glucocorticoids produced in fasciculata adrenal cortex, Conn’s syndrome, arises from an hypersecretion of aldosterone produced by glomerulosa adrenal cortex, and Pheochromocytomas that arise from adrenal medulla and produce catecholamines. Sometimes, bilateral adre- nalectomy may be required in Cushing's disease due to pituitary or ectopic ACTH secretion. Adenomas arise from the reticularis layer of the adrenal cortex, which rarely releases too much adrenal androgen and estrogen, may also develop and have an indication for adrenalectomy. Adrenal surgery can be performed by laparoscopic or open technique. Today, laparoscopic adrenalectomy is the gold standard treatment in selected patients. Laparoscopic adrenalectomy can be performed transperitoneally or retroperitoneoscopi- cally. Both approaches have their advantages and disadvantages. In the selection of the surgery type, the experience and habits of the surgeon are also important, along with the patient’s characteristics. The most common type of surgery performed in the world is laparoscopic transabdominal lateral adrenalectomy, which most surgeons are more familiar with.
    [Show full text]
  • Ese-Ensat-Acc-Guidelines-13-5-2018
    European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors Martin Fassnacht1,2*, Olaf M. Dekkers3,4,5, Tobias Else5, Eric Baudin7,8, Alfredo Berruti9, Ronald R. de Krijger10, 11, 12, 13, Harm R. Haak14,15, 16, Radu Mihai17, Guillaume Assie19, 20, Massimo Terzolo20* 1 Dept. of Internal Medicine I, Div. of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany 2 Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany 3 Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands 4 Department of Clinical Endocrinology and Metabolism, Leiden University Medical Centre, Leiden, the Netherlands 5 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark 6 Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA 7 Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France 8 INSERM UMR 1185, Faculté de Médecine, Le Kremlin-Bicêtre, Université Paris Sud, Paris, France 9 Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Medical Oncology, University of Brescia at ASST Spedali Civili, Brescia, Italy. 10 Dept. of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands 11 Dept. of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands 12 Dept. of Pathology, Reinier de Graaf Hospital, Delft, The Netherlands 13 Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands 14 Department of Internal Medicine, Máxima Medical Centre, Eindhoven/Veldhoven, the Netherlands 15 Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, the Netherlands 16 Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.
    [Show full text]
  • Hyperparathyroidism
    HYPERPARATHYROIDISM Edited by Gonzalo Díaz-Soto and Manuel Puig-Domingo Hyperparathyroidism Edited by Gonzalo Díaz-Soto and Manuel Puig-Domingo Published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia Copyright © 2012 InTech All chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech, authors have the right to republish it, in whole or part, in any publication of which they are the author, and to make other personal use of the work. Any republication, referencing or personal use of the work must explicitly identify the original source. As for readers, this license allows users to download, copy and build upon published chapters even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials, instructions, methods or ideas contained in the book. Publishing Process Manager Romana Vukelic Technical Editor Teodora Smiljanic Cover Designer InTech Design Team First published April, 2012 Printed in Croatia A free online edition of this book is available at www.intechopen.com Additional hard copies can be obtained from [email protected] Hyperparathyroidism, Edited by Gonzalo Díaz-Soto and Manuel Puig-Domingo p.
    [Show full text]
  • Hormonally Active Adrenocortical Carcinoma in a 24-Year Old Woman
    ACS Case Reviews in Surgery Vol. 1, No. 1 Hormonally active adrenocortical carcinoma in a 24-year old woman AUTHORS: CORRESPONDENCE AUTHOR: AUTHOR AFFILIATIONS: Wachtel H1-4, Sadow PM2,4, Stathatos N3,4, Dr. Carrie Lubitz, MD, FACS 1 Massachusetts General Hospital, Dept. of Surgery, Lubitz CC1,4 Massachusetts General Hospital Div. of General & Endocrine Surgery, Boston, MA Yawkey Center for Outpatient Care, 7B 2 Massachusetts General Hospital, Dept. of 55 Fruit Street Pathology, Boston, MA Boston, MA 02114 3 Massachusetts General Hospital, Dept. of Phone: 617-643-9473 Medicine, Div. of Endocrinology, Boston, MA Fax: 617-724-3895 4 Harvard Medical School, Boston, MA Email: [email protected] Background Adrenal tumors are common and frequently identified incidentally; adrenalectomy is indicated for functional tumors, masses ≥4 cm, and cases where malignancy is suspected. Summary A 24-year old previously healthy woman presented with a six-month history of weight gain, amenorrhea, hirsutism, acne, and hypertension. Biochemical evaluation revealed hypercortisolism and elevated DHEA-S. Abdominal imaging demonstrated an 11 cm right adrenal mass, abutting the right hepatic lobe, right kidney, and inferior vena cava. The patient underwent open right adrenalectomy for the presumptive diagnosis of hormonally active adrenocortical carcinoma (ACC). The tumor was able to be mobilized from surrounding structures without requiring resection of adjacent organs. Pathological exam demonstrated a 728 g, 16.5 cm ACC with extensive necrosis, and Ki67 proliferation index of 35% and large vessel vascular invasion. Postoperatively, the symptoms of hypercortisolism, virilization, and hypertension resolved. The patient is currently undergoing adjuvant mitotane therapy and has no evidence of disease six months after surgery.
    [Show full text]
  • Thyroid & Parathyroid Surgery
    Thyroid & Parathyroid Surgery – Frequently Asked Questions How long will the operation take? What about neck stiffness and exercises? Thyroid and parathyroid operations generally take between one to Some neck stiffness is common as a result of the prolonged three hours. extension (backward tilting) of the head under the anaesthetic. The exercises recommended will reduce it but it may last for some Will I need a general anaesthetic? weeks and require physiotherapy as well. This type of surgery requires a general anaesthetic in order to stop Will my parathyroid glands be taken out with my thyroid? muscle movement during the delicate dissection. Often the anaesthetic is supplemented by local anaesthetic or a nerve block, If you are having thyroid surgery ("thyroidectomy") then every this may result in you having a numb face and ear for 24 hours attempt is made to preserve all your parathyroid glands. Mostly afterwards. they are left in place with their blood supply attached but, if that is not technically possible, they may need to be removed and How long will my incision be and where will it be placed? transplanted into the adjacent muscle. Sometimes very small parathyroid glands are buried under the thyroid capsule and For open thyroid or parathyroid surgery the scar is a curved line in cannot be identified at operation and so get taken out with the the "collar" position, about 2cm above the collar bone. The length thyroid specimen. Transplanted parathyroid glands take between varies depending on the size of the lump removed. For minimally 6 weeks to 6 months to recover, however the body can generally invasive surgery the scar is only 2 to 3cm long and is placed on get by with just part of one parathyroid gland if necessary.
    [Show full text]
  • Thyroidectomy –
    Thyroidectomy – an operation to remove all or part of the thyroid gland Information for patients page 2 What is the thyroid gland? The thyroid gland is an endocrine gland which makes hormones that are released into the bloodstream. These hormones affect cells and tissues in other parts of the body and help them to function normally. The thyroid is made up of two lobes, each about half the size of a plum. The two lobes lie on either side of your windpipe, with the gland as a whole lying just below your Adam’s apple. The thyroid gland produces three hormones, that are released into the bloodstream: • thyroxine, often called T4 • triiodothyronine, often called T3. In the body, T4 is converted into T3 and this is what influences the way cells and tissues work. • calcitonin – this is involved in controlling calcium levels in the blood. With medullary thyroid cancer (MTC), too much calcitonin is produced, however this does not lead to any significant change in calcium levels. Thyroxine and T3 can both be replaced by medication and the body can function perfectly well with little or no calcitonin. Thyroid hormones T3 and T4 help to control the speed of body processes – otherwise known as your metabolic rate. If too much of these thyroid hormones is released, your body starts to work faster than normal and you develop ‘hyperthyroidism’. This would make you feel overactive and anxious, hungrier than usual, and you would lose weight. However, if too little of these thyroid hormones is produced, your body will start to work slower than normal and you develop ‘hypothyroidism’.
    [Show full text]
  • Journal of Endocrine Surgery
    ORIGINAL ARTICLE The Korean Journal of ISSN 1598-1703 (Print) ISSN 2287-6782 (Online) Korean J Endocr Surg 2014;14:219-227 Endocrine Surgery http://dx.doi.org/10.16956/kaes.2014.14.4.219 Surgical Outcomes of Adrenocortical Carcinoma; 20 Years of Experience in a Single Institution Min Jhi Kim, Eun Jeong Ban, Soo Jung Jung, Hai Young Son1, Cho Rok Lee, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Cheong Soo Park Department of Surgery, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, 1International St. Mary’s Hospital, Incheon, Korea Purpose: Adrenocortical carcinoma (ACC) is a rare malignant tumor. Early detection is difficult and prognosis is poor. We report on 20 years of ACC surgical experience at our institution. Methods: This study included 32 ACC patients who underwent surgical resection at the Department of Surgery of the Yonsei University Health System in South Korea between January 1990 and February 2012. We reviewed these 32 patients and retrospectively analyzed long-term clinical outcomes and prognosis after radical surgery for ACC. Results: The median age of the 32 patients at diagnosis was 42.25 years (range 3∼81 years). There were 16 (50%) female and 16 (50%) male patients. Mean tumor size was 12.36 cm (range 1.8∼20 cm). Twenty-five patients (78.12%) had nonfunctioning tumors while the other seven patients (21.87%) had functioning tumors. Seventeen patients (53.12%) were classified as stage II, two (6.25%) as stage III, and 13 (40.62%) as stage IV. Fourteen patients underwent radical surgical resection, while 14 patients received adjuvant chemotherapy, two received adjuvant radiotherapy, and two received adjuvant chemora- diation.
    [Show full text]
  • MEN1-Related Pancreatic Nets: Identification of Unmet Clinical
    27 8 Endocrine-Related C R C Pieterman, Future directives in 27:8 T9–T25 Cancer S M Sadowski et al. MEN1-related PanNETs THEMATIC REVIEW HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES MEN1-related pancreatic NETs: identifcation of unmet clinical needs and future directives C R C Pieterman1,2,*, S M Sadowski3,*, J E Maxwell4, M H G Katz4, K E Lines5, C M Heaphy6,†, A Tirosh7, J E Blau8, N D Perrier1, M A Lewis9,10, J P Metzcar11,12, D M Halperin13, R V Thakker5 and G D Valk2 1Section of Surgical Endocrinology, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands 3Endocrine Surgery, Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 4Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Academic Endocrine Unit, Radclife Department of Medicine, OCDEM, University of Oxford, Oxford, UK 6Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 7Neuroendocrine Tumors Service, Division of Endocrinology, Metabolism and Diabetes, The Chaim Sheba Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 8Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA 9Gastrointestinal Oncology, Intermountain
    [Show full text]
  • ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
    ENETS Consensus Guidelines Neuroendocrinology 2016;103:153–171 Published online: January 5, 2016 DOI: 10.1159/000443171 ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors a b c d e f M. Falconi B. Eriksson G. Kaltsas D.K. Bartsch J. Capdevila M. Caplin g h i j k l B. Kos-Kudla D. Kwekkeboom G. Rindi G. Klöppel N. Reed R. Kianmanesh m R.T. Jensen all other Vienna Consensus Conference participants a b Department of Surgery, San Raffaele Hospital, Università Vita e Salute, Milan , Italy; Department of Endocrine Oncology, c University Hospital, Uppsala , Sweden; Department of Pathophysiology, Division of Endocrinology, National University d e of Athens, Athens , Greece; Department of Surgery, Philipps University, Marburg , Germany; Institute of Oncology f (VHIO), Vall d’Hebron University Hospital, Barcelona , Spain; Neuroendocrine Tumour Unit, Royal Free Hospital, London , g h UK; Department of Endocrinology, Medical University of Silesia, Katowice , Poland; Department of Internal Medicine, i Division of Nuclear Medicine, Erasmus Medical Center, Rotterdam , The Netherlands; Institute of Anatomic Pathology, j Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome , Italy; Institute of Pathology, Technische Universität k l München, Munich , Germany; Beatson Oncology Centre, Gartnavel General Hospital, Glasgow , UK; Department of m Surgery, CHU Robert Debré, Reims , France; Digestive Diseases Branch, NIH, Bethesda, Md. , USA Introduction be considered in three groups: the more frequent gastri- nomas and insulinomas considered independently and Only advances that occurred from 2011 to 2014 that all the rare F-P-NETs (RFTs) considered together and as either strengthen the previous 2011 guidelines [1, 2] or a separate category (Appendix 1 and table 1).
    [Show full text]
  • Tqehresearch 2009 Research Report
    TQEHresearch 2009 Research Report TQEHresearch 2009 Research Report Contents 04 DIRECTOR OF RESEARCH REPORT 06 2009 RESEARCH PUBLICATIONS IN THE SPOTLIGHT 09 ANAESTHESIA, Department of 10 CARDIOLOGY UNIT 18 CLINICAL PHARMACOLOGY UNIT 21 DERMATOLOGY UNIT 22 ENDOCRINOLOGY UNIT 24 GASTROENTEROLOGY AND HEPATOLOGY UNIT 26 GYNAECOLOGY, Department of 28 HAEMATOLOGY AND MEDICAL ONCOLOGY, The combined Departments of 34 INTENSIVE CARE UNIT 39 MEDICINE, University of Adelaide Discipline of 44 NEUROLOGY UNIT 51 NUCLEAR MEDICINE UNIT 54 NURSING RESEARCH 55 OTOLARYNGOLOGY, HEAD AND NECK SURGERY, Department of 59 PSYCHIATRY, University of Adelaide Discipline of 61 RENAL UNIT 68 RESPIRATORY MEDICINE UNIT 70 RHEUMATOLOGY UNIT 72 SURGERY, University of Adelaide Discipline of 77 THERAPEUTICS RESEARCH CENTRE, University of South Australia 80 PUBLICATIONS 93 INVITED PRESENTATIONS 105 RESEARCH SUPPORT STRUCTURES 111 AWARDS 115 ACKNOWLEDGEMENTS 116 THE QUEEN ELIZABETH HOSPITAL RESEARCH FOUNDATION TQEHresearch Research Report 2009 2 TQEHresearch Research Report 2009 3 Professor Guy Maddern Director of Research Director of Research Report The Basil Hetzel Institute 2009 began with great enthusiasm as Alongside this move towards translational for Medical Research The groups moved into The Basil Hetzel Institute research has been the development of the Queen Elizabeth Hospital building at The Queen Elizabeth Hospital. South Australian Health and Medical Research Like all new buildings, there have been the Institute on North Terrace. The Common- inevitable problems in resolving small but wealth Government has allocated $200 irritating technical glitches but, at the time million to this new capital development and of writing this report, all but one major it is envisaged that it will have a central role problem has been satisfactorily resolved and for research in South Australia with a close the groups are enjoying their new environ- relationship to its nodes, such as the Basil ment.
    [Show full text]